I sold earlier this year after SPPI broke $2 (to the upside)for what I thought at the time was a nice gain. I was concerned that Zevalin sales would disappoint, due to competition from Treanda in the salvage NHL setting and that 1st line -consolidation would not be as big as some were expecting after attending a Hem conference in Whistler in Feb. In retrospect, I should not have gotten scared out of the stock.